HER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive.
about
Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.A new strategy to ERADicate HER2-positive breast tumors?Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition.The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.Selective DNA methylation in cancers controls collateral damage induced by large structural variationsTargeting protein quality control pathways in breast cancer.
P2860
HER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HER2-mTOR signaling-driven bre ...... ciated degradation to survive.
@en
type
label
HER2-mTOR signaling-driven bre ...... ciated degradation to survive.
@en
prefLabel
HER2-mTOR signaling-driven bre ...... ciated degradation to survive.
@en
P2093
P2860
P1433
P1476
HER2-mTOR signaling-driven bre ...... ciated degradation to survive.
@en
P2093
Kakajan Komurov
Navneet Singh
Rashika Joshi
P2860
P356
10.1126/SCISIGNAL.AAA6922
P577
2015-05-26T00:00:00Z